SCHEMBL20144184

SCHEMBL20144184

CCOC(=O)[C@H](C)NP(=O)(N[C@@H](C)C(=O)OCC)OC

nearest known ligand 0.41

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.41
CYP3A4 P08684 2/20 0.41
ALOX15 P16050 2/20 0.41
TSHR P16473 2/20 0.41
TDP1 Q9NUW8 1/20 0.41
BTN3A1 O00481 4/20 0.39
MGAM O43451 1/20 0.38
GAA P10253 1/20 0.38
SI P14410 1/20 0.38
MGAM2 Q2M2H8 1/20 0.38
HSD17B10 Q99714 2/20 0.37
CHRM1 P11229 1/20 0.37
ADORA1 P30542 1/20 0.37
METAP2 P50579 8/20 0.36
METAP1 P53582 6/20 0.36
FBP1 P09467 1/20 0.34
LMNA P02545 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21343018 0.86 ALDH1A1 (0.40) ALDH1A1CYP3A4ALOX15TSHRTDP1
SCHEMBL18667169 0.86 BTN3A1 (0.35) ALDH1A1CYP3A4ALOX15TSHRTDP1
SCHEMBL28855412 0.83 ALDH1A1 (0.41) ALDH1A1CYP3A4ALOX15TSHRTDP1
SCHEMBL25893454 0.82 BTN3A1 (0.41) ALDH1A1CYP3A4ALOX15TSHRTDP1
SCHEMBL28273778 0.82 MGAM (0.39) ALDH1A1BTN3A1MGAMGAASI
SCHEMBL20181544 0.82 MGAM (0.39) ALDH1A1BTN3A1MGAMGAASI
SCHEMBL13633863 0.82 MGAM (0.39) ALDH1A1CYP3A4ALOX15TSHRTDP1
SCHEMBL27494852 0.82 MGAM (0.39) ALDH1A1BTN3A1MGAMGAASI
SCHEMBL12746435 0.82 MGAM (0.39) ALDH1A1CYP3A4ALOX15TSHRTDP1
SCHEMBL19225305 0.82 MGAM (0.39) ALDH1A1CYP3A4ALOX15TSHRTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3785717-B1 METHODS FOR TREATING CORONAVIRIDAE INFECTIONS GILEAD SCIENCES INC (US) 2022-01-05 EP disclosed
EP-3212175-B1 METHODS FOR THE PREPARATION OF RIBOSIDES GILEAD SCIENCES INC (US) 2021-11-24 EP disclosed
EP-3785717-A1 METHODS FOR TREATING CORONAVIRIDAE INFECTIONS Gilead Sciences, Inc. (US) 2021-03-03 EP disclosed
EP-3695844-A1 METHODS FOR TREATING NIPAH VIRUS INFECTIONS Gilead Sciences, Inc. (US) 2020-08-19 EP disclosed
EP-3212174-B1 METHODS FOR TREATING FILOVIRIDAE VIRUS INFECTIONS GILEAD SCIENCES INC (US) 2018-05-16 EP disclosed